Search - tctmd.com

Displaying 1 - 20 of 43

Sort: Relevancy | Date

Presentation TCT 2025

Establishing Optimum Stent Implantation Standards to Minimize Stent Failure

Presenter: Tom Johnson

October 28, 2025

Presentation TCT 2024

The Optimum Short Frame Self-Expanding TAVR System (Optimum TAV)

Presenter: Jaroslaw Trebacz

October 28, 2024

News Daily News

Standing Alone Will Not Offset Sitting’s CVD Risks, Study Suggests

Todd Neale

October 21, 2024

Presentation NY Valves 2024

Feasibility Study of a New Short, Self-Expanding TAVR Valve: Optimum TAV

Presenter: Jaroslaw Trebacz

June 06, 2024

Presentation TVT 2023

Early Clinical Experience with A New Short, Self-Expanding, Transcatheter Aortic Valve: Optimum-TAV

Presenter: Mathew Williams

June 08, 2023

News Features

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

L.A. McKeown

May 12, 2023

News Daily News

Surgical Turndown Patients Need Better Risk Estimation Tools: OPTIMUM

Yael L. Maxwell

February 15, 2023

News Daily News

Heart Risks Higher With Moderna vs Pfizer/BioNTech Shot, Direct Comparison Shows

Caitlin E. Cox

November 09, 2022

Presentation TCT 2022

Percutaneous MCS Support for PCI in Surgically Ineligible Patients: Preliminary Results from Optimum

Presenter: Adam Salisbury

September 18, 2022

Podcast TCTMD Talking Points

The OPTIMUM Trial

June 22, 2022

News Conference News TCT 2021

Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM

Michael O'Riordan

November 04, 2021

Presentation TCT 2021

OPTIMUM: Early Outcomes From a Prospective Registry of PCI in Patients at Prohibitive Risk for CABG

Presenter: David Kandzari

November 04, 2021

News Daily News

‘Nontrivial’ Amount of LA Thrombus Found Before AF Procedures

Todd Neale

June 08, 2021

News Daily News

Mom’s CV Health in Pregnancy Foretells Child’s Risk Years Later

L.A. McKeown

February 17, 2021

Presentation TCT 2019

Optimum Transcatheter Aortic Valve: Global First-in-Human

Presenter: Mathew Williams

September 27, 2019

News Daily News

Trial Points to Possible Benefit of Intensive BP-Lowering to Stave Off Recurrent Stroke

Todd Neale

July 29, 2019

Presentation TVT 2019

OPTIMUM TAV First-In-Human Results

Presenter: Mathew Williams

June 13, 2019

News Daily News

Now You See It: Imaging Helps Lower CVD Risk Burden in Primary Prevention

Michael O'Riordan

December 10, 2018

News Industry News

Concept Medical Inc. Raises $60mn For Investigational Device Exemption (IDE) For The World’s First Sirolimus-Coated Balloon

October 10, 2018

Presentation

The Learning Curve and Annual Procedure Volume Standards for Optimum TAVR Outcomes

September 11, 2018

Advertisement

Establishing Optimum Stent Implantation Standards to Minimize Stent Failure

The Optimum Short Frame Self-Expanding TAVR System (Optimum TAV)

Standing Alone Will Not Offset Sitting’s CVD Risks, Study Suggests

Feasibility Study of a New Short, Self-Expanding TAVR Valve: Optimum TAV

Early Clinical Experience with A New Short, Self-Expanding, Transcatheter Aortic Valve: Optimum-TAV

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

Surgical Turndown Patients Need Better Risk Estimation Tools: OPTIMUM

Heart Risks Higher With Moderna vs Pfizer/BioNTech Shot, Direct Comparison Shows

Percutaneous MCS Support for PCI in Surgically Ineligible Patients: Preliminary Results from Optimum

The OPTIMUM Trial

Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM

OPTIMUM: Early Outcomes From a Prospective Registry of PCI in Patients at Prohibitive Risk for CABG

‘Nontrivial’ Amount of LA Thrombus Found Before AF Procedures

Mom’s CV Health in Pregnancy Foretells Child’s Risk Years Later

Optimum Transcatheter Aortic Valve: Global First-in-Human

Trial Points to Possible Benefit of Intensive BP-Lowering to Stave Off Recurrent Stroke

OPTIMUM TAV First-In-Human Results

Now You See It: Imaging Helps Lower CVD Risk Burden in Primary Prevention

Concept Medical Inc. Raises $60mn For Investigational Device Exemption (IDE) For The World’s First Sirolimus-Coated Balloon

The Learning Curve and Annual Procedure Volume Standards for Optimum TAVR Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content